On November 15, PhRMA’s President and Chief Executive Officer, Stephen J. Ubl, joined Matthew Herper at the STAT Summit to discuss the newly enacted Inflation Reduction Act and how the law harms biopharmaceutical R&D and doesn’t do enough to address patient affordability and access.

When:  

November 15, 2022, at 2:30 p.m. ET 

Speakers: 

• Stephen J. Ubl, President and Chief Executive Officer, PhRMA
• Matthew Herper, Senior Writer, Medicine, Editorial Director of Events, STAT (moderator)